Enabling manufacture and access to advanced therapy medicinal products in low- and middle-income countries

2025/07/15 by Antônio Carlos Campos de Carvalho, Antonio Carlos Campos de Carvalho, Camile Giaretta Sachetti +1 · 1 voice · 1 citation
Medicine · #Biomedical Ethics and Regulation #Biotechnology and Related Fields #CAR-T cell therapy research

paper · doi:10.1016/j.hlife.2025.07.001

openalex publication_date 2025/07/15 · crossref created 2025/07/15 · openalex created_date 2025/10/10 · crossref issued 2025/11/01 · crossref published 2025/11/01 · crossref published-print 2025/11/01 · crossref deposited 2026/05/01 · crossref indexed 2026/05/04 · openalex updated_date 2026/07/23

Citations

• Baby genomics: newborn sequencing starts to fulfill its promise

Cited by

• Diagnostics for human pathogenic fungal infections: Current status and future prospects

Discussions

• The research group of Professor Antonio Carlos Campos de Carvalho has summarized that Brazil has developed a model enabling the manufacture of and access to advanced therapy medicinal products in low- [bsky, 3 points, 0 comments]